BTK-IN-29, CAS [[2736508-60-2]]

Produktübersicht

• Artikelname: BTK-IN-29, CAS [[2736508-60-2]]
• Artikelnummer: TGM-T85921
• Hersteller Artikelnummer: T85921
• Alternativnummer: TGM-T85921-1MLX10MM(INDMSO), TGM-T85921-1MG, TGM-T85921-5MG, TGM-T85921-10MG, TGM-T85921-25MG, TGM-T85921-50MG, TGM-T85921-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: BGB-16673 , Catadegbrutinib

Produktbeschreibung

BTK-IN-29 is a selective, orally active BTK degrader (IC50=0.69 nM) capable of degrading the entire BTK protein and counteracting BTK mutations. It can be used to study B-cell malignancies such as chronic lymphocytic leukemia, small lymphocytic lymphoma, mantle cell lymphoma, and others.

Produkteigenschaften

• Molekulargewicht: 851.01
• Reinheit: 99.99%
• CAS Nummer: [2736508-60-2]
• Formel: C47H54N12O4
• Target-Kategorie: BTK|||PROTACs